Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Common Equity (2016 - 2026)

Scynexis filings provide 14 years of Common Equity readings, the most recent being $41.3 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 18.26% to $41.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $41.3 million, a 18.26% decrease, with the full-year FY2025 number at $49.4 million, down 10.35% from a year prior.
  • Common Equity hit $41.3 million in Q1 2026 for Scynexis, down from $49.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $93.1 million in Q2 2023 to a low of -$29.9 million in Q1 2023.
  • Median Common Equity over the past 5 years was $49.4 million (2025), compared with a mean of $47.2 million.
  • The widest YoY moves for Common Equity: up 2156.79% in 2023, down 176.85% in 2023.
  • Scynexis' Common Equity stood at $3.2 million in 2022, then skyrocketed by 2156.79% to $73.0 million in 2023, then fell by 24.51% to $55.1 million in 2024, then decreased by 10.35% to $49.4 million in 2025, then fell by 16.34% to $41.3 million in 2026.
  • The last three reported values for Common Equity were $41.3 million (Q1 2026), $49.4 million (Q4 2025), and $36.4 million (Q3 2025) per Business Quant data.